Status: Recruiting
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
The goal of this clinical trial is to determine the efficacy of IMC-001 in metastatic or locally advanced TMB-H solid tumor patients.
Participants needed: 30
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: ImmuneOncia Therapeutics Inc.Updated: Apr 17, 2026Locations: 4
Eligibility criteria
Documented TMB-H:≥ 16 mut/Mb, determined by the TruSightTM Oncology 500 NGS pane... [+13]
Previously treated with an anti-PD-L1 or anti-PD-1 antibody [+4]